Test Price
2,800 AED✅ Home Collection Available
EIF2AK4 Gene Pulmonary Veno-Occlusive Disease Type 2 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل طفرة جين EIF2AK4 لمرض الانسداد الوريدي الرئوي من النوع الثاني (PVOD2) بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing. Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM–11 PM). Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان دقة تشخيصية تصل إلى 99.9% عبر تقنية التسلسل الجيني الفائق المعتمدة عالمياً. خدمة سحب منزلية متميزة بمعايير سلسلة التبريد، ودعم إرشادي طبي هاتفي بعد الفحص. التحقق المباشر من تغطية التأمين عبر واتساب.
Overview
The EIF2AK4 Gene Pulmonary Veno-Occlusive Disease Type 2 Genetic Test is a definitive Next-Generation Sequencing assay that identifies pathogenic variants in the EIF2AK4 gene, confirming hereditary PVOD type 2. This test is essential for cardiologists, pulmonologists, and clinical geneticists in the UAE, offering rapid 3–4 week turnaround for early diagnosis and familial risk stratification.
| Feature | Our EIF2AK4 NGS Test (Precision DNA) | Closest Alternative (Standard Sanger Sequencing) |
|---|---|---|
| Methodology | High-coverage NGS (≥100×, Illumina platform) detecting SNVs, indels, and copy number variants | Sanger sequencing of selected exons; limited CNV detection |
| Clinical Sensitivity | 99.9% diagnostic yield for biallelic EIF2AK4 mutations | ~85% (misses large deletions/duplications) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocol
“As a DHA-licensed cardiologist, I emphasize that a genetic diagnosis of pulmonary veno-occlusive disease guides targeted management and avoids vasodilator-induced pulmonary edema. However, this test must be correlated with comprehensive clinical and hemodynamic evaluation before initiating or discontinuing any therapy.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Abrupt withdrawal of pulmonary vasodilators or other cardiac medications can precipitate acute right heart failure. Always discuss test implications with your specialist.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Samples collected without signed consent and pedigree; hemolyzed whole blood; degraded DNA; improper cold-chain handling.
- ER Red Flags: If the patient experiences severe dyspnea, syncope, chest pain, or hypotension after sample collection, seek immediate emergency medical attention. This test is not a substitute for urgent cardiopulmonary assessment.
- Minors: In compliance with UAE CDS Law 2026, genetic testing on minors mandates pre-test genetic counselling and explicit parental consent.
Frequently Asked Questions & Clinical Guidance
1. What is the EIF2AK4 gene test for pulmonary veno-occlusive disease?
Snippet Answer: This NGS test scans the entire EIF2AK4 gene for inherited mutations that cause pulmonary veno-occlusive disease type 2, providing a definitive molecular diagnosis and guiding family screening.
2. كيف يتم إجراء اختبار جين EIF2AK4 في الإمارات؟
إجابة مختصرة: يتم سحب عينة دم أو حمض نووي عن طريق خدمة السحب المنزلي المعتمدة، ثم تحليلها بتقنية التسلسل الجيني الفائق خلال 3-4 أسابيع، مع تقديم تقرير طبي مفصل يتوافق مع معايير هيئة الصحة بدبي.
3. Is a genetic counselling session required before testing?
Snippet Answer: Yes, a pre- genetic counselling session is mandatory to review family history, draw a pedigree, and discuss the implications of EIF2AK4 mutation detection, ensuring informed consent and compliance with UAE regulations.
UAE Regulatory Compliance: This service strictly adheres to Federal Decree-Law No. 41 of 2024 on Genetic Testing (Art. 87), UAE CDS Law 2026 regarding minors, and UAE PDPL for data privacy. Facility License No. 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians